Loading market data...
Latest Top News
Dr Lalchandani Labs Accelerates Expansion with ₹43.3 Cr Rights Issue Approval
Dr Lalchandani Labs Ltd's board approved a rights issue of up to ₹43.33 crore via equity shares on December 15, 2025, targeting eligible shareholders. This funding supports diagnostics growth amid regulatory nods under SEBI ICDR norms.
Stay Ahead – Explore Now! India Must Build Its Own Clean Energy Talent Pool to Hit 2030 Climate Goals






